Description:

Xembify

Generic name: immune globulin (intramuscular route, intravenous route, subcutaneous route)

Intravenous route(Powder for Solution;Solution)

Thrombosis may occur with or without known risk factors, including advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, estrogen use, indwelling central vascular catheters, hyperviscosity, and cardiovascular risk factors . For patients at risk of thrombosis, administer immune globulin at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration; monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity . Renal dysfunction, acute renal failure, osmotic nephrosis, and death may occur in predisposed patients who receive immune globulin IV (IGIV) products. Patients predisposed to renal dysfunction include those with any degree of preexisting renal insufficiency, diabetes mellitus, age greater than 65, volume depletion, sepsis, paraproteinemia, or patients receiving known nephrotoxic drugs. Higher rates of renal failure were associated with IGIV products that contain sucrose . The following products do not contain sucrose: Gammaplex(R), Bivigam(R), Octagam(R) 10%, Gamunex(R)-C, Gammagard Liquid(R), Gammagard S/D, Gammaked(TM), Flebogamma(R) 5% DIF, Flebogamma(R) 10% DIF, Privigen(R), and Hizentra(R) .

Intramuscular route(Solution)

Thrombosis may occur with immune globulin products. Risk factors may include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling central vascular catheters, hyperviscosity, and cardiovascular risk factors. Thrombosis may occur in the absence of known risk factors.For patients at risk of thrombosis, do not exceed the recommended dose. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity .

Subcutaneous route(Solution)

Warning: ThrombosisThrombosis may occur with immune globulin products, including immune globulin-hipp. Risk factors may include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling central vascular catheters, hyperviscosity, and cardiovascular risk factors. Thrombosis may occur in the absence of known risk factors.For patients at risk of thrombosis, administer immune globulin-hipp at the minimum dose and infusion rates practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk of hyperviscosity .

Intravenous route(Solution)

Warning: Thrombosis, Renal Dysfunction, and Acute Renal FailureThrombosis may occur with immune globulin intravenous (IGIV) products, including immune globulin-ifas. Risk factors may include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling vascular catheters, hyperviscosity, and cardiovascular risk factors.Renal dysfunction, acute renal failure, osmotic nephropathy, and death may occur with the administration of IGIV products in predisposed patients. Renal dysfunction and acute renal failure occur more commonly in patients receiving IGIV products containing sucrose. Immune globulin-ifas does not contain sucrose.For patients at risk of thrombosis, renal dysfunction, or renal failure, administer immune globulin-ifas at the minimum infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity .

Subcutaneous route(Solution)

Warning: ThrombosisThrombosis may occur with immune globulin products, including immune globulin-klhw. Risk factors may include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling central vascular catheters, hyperviscosity, and cardiovascular risk factors. Thrombosis may occur in the absence of known risk factors.For patients at risk of thrombosis, administer immune globulin-klhw at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity .

Subcutaneous route(Solution)

Warning: ThrombosisThrombosis may occur with immune globulin products, including immune globulin-slra. Risk factors may include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling central vascular catheters, hyperviscosity, and cardiovascular risk factors. Thrombosis may occur in the absence of known risk factors.Renal dysfunction, acute renal failure, osmotic nephrosis, and death may occur with the administration of immune globulin IV (IGIV) products in predisposed patients.Renal dysfunction and acute renal failure occur more commonly in patients receiving IGIV products containing sucrose. Immune globulin-slra does not contain sucrose.For patients at risk of thrombosis, administer immune globulin-slra at the minimum dose and infusion rates practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk of hyperviscosity .

Commonly used brand name(s)

In the U.S.

Asceniv
Baygam
Bivigam
Carimune
Cutaquig
Cuvitru
Flebogamma 10% DIF
Flebogamma 5%
Flebogamma 5% DIF
GamaSTAN
Gamastan S/D
Gamimune N
Gammagard
Gammagard S/D
Gammaplex
Gammaplex 10%
Gammar-P
Gamunex
Hizentra
Iveegam EN
Octagam
Octagam 10%
Panglobulin NF
Panzyga
Polygam S/D
Privigen
Sandoglobulin
Venoglobulin-S
Vivaglobin
Xembify

Available Dosage Forms:

Powder for Solution
Solution

Therapeutic Class: Immune Serum

Uses for Xembify

Immune globulin injection is used to prevent infections or make the infection less severe (eg, hepatitis A with not more than 2 weeks of exposure, chickenpox, measles with not more than 6 days of exposure, has not been vaccinated, and has not had measles previously, or rubella) when your body has a weak immune system. Immune globulin contains antibodies that make your immune system stronger. It is used for patients who have primary humoral immunodeficiency (PI), idiopathic thrombocytopenic purpura (ITP), chronic immune thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy (CIDP), or dermatomyositis (DM). It is also used to improve muscle strength and disability in patients with multifocal motor neuropathy (MMN). Immune globulin injection belongs to a group of medicines known as immunizing agents.

This medicine is to be given only by or under the supervision of your doctor.

Before using Xembify

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of immune globulin injection in children. Some of the products are only used in children who are 2, 3, or 15 years of age and older, and other products are not approved for use in children. Immune globulin injection is used to treat primary humoral immunodeficiency (PI), idiopathic thrombocytopenic purpura (ITP), and chronic immune thrombocytopenic purpura in children. Safety and efficacy have not been established for use in chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy (MMN), or dermatomyositis (DM).

Appropriate studies have not been performed on the relationship of age to the effects of Gamastan® in the pediatric population. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of immune globulin injection in the elderly. However, elderly patients are more likely to have age-related blood clotting problems, kidney disease, or heart disease, which may require caution for patients receiving immune globulin injection.

Appropriate studies have not been performed on the relationship of age to the effects of Gamastan® in the elderly. Safety and efficacy have not been established.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

Ravulizumab-cwvz

Interactions with food/tobacco/alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Proper use of Xembify

This section provides information on the proper use of a number of products that contain immune globulin. It may not be specific to Xembify. Please read with care.

A doctor or other trained health professional will give you this medicine in a medical facility. It is given through a needle placed into one of your veins, as a shot into one of your muscles, or as a shot under your skin.

This medicine comes with a patient information insert. Read and follow the instructions carefully. Ask your doctor if you have any questions.

While you are being treated with immune globulin injection, do not have any immunizations (vaccines) without your doctor''s approval. Live virus vaccines should not be given for 3 to 6 months after receiving immune globulin.

The Gammagard Liquid, Gammaked™, Gamunex®-C, and Hizentra® products may be given at home to patients who do not need to be in the hospital or clinic. They are given as an infusion under your skin once every week. Cuvitru® and Hizentra® products may also be given once every 2 weeks. If you are using this medicine at home, your doctor will teach you how to prepare and infuse the medicine. You will be shown the body areas where the medicine can be given. Use a different body area for each infusion. Keep track of where you give an infusion to make sure you rotate sites. This will help prevent skin problems.

Do not change the brand or type of your immune globulin unless your doctor tells you to. If you must change the brand of medicine, talk to your doctor before giving yourself an infusion. Make sure you understand the instructions on how to use the new brand.

Allow the Gammagard Liquid, Gammaked™, or Gamunex®-C brand to reach room temperature before using it.

To use Cuvitru®, Gammagard Liquid, Gammaked™, Gamunex®-C, or Hizentra®:

First, gather the items you will need on a clean, flat surface using a cloth or towel in a well-lighted area.
Wash your hands with soap and water before and after using this medicine.
If you have been told to wear gloves when preparing your infusion, put the gloves on.
Check the liquid in the vial (glass container). It should be clear and slightly yellow to light brown in color. If it is cloudy, discolored, or contains large flecks (particles), do not use the vial. Select another vial.
If the liquid is clear, place it on the clean, flat surface. Do not heat up or shake the medicine.
Follow your doctor''s instructions on how to prepare the correct amount of medicine.
Choose an injection site on your body (eg, stomach area, thigh, upper arm, upper leg, hip). Clean the injection site with a fresh alcohol wipe, and let it dry.
With two fingers, pinch together the skin at the injection site. Insert the needle with the tube under the skin.
Put sterile gauze and tape over the injection site to keep the needle from coming out.
Before starting the infusion, make sure no blood is flowing into the infusion tube. If blood is present, remove and throw away the used needle and tube.
Follow your doctor''s instructions on how to use the infusion pump.
Remove the peel-off portion of the label from the used vial. Place this label in your treatment diary or log book. Write down the amount of medicine you used, the date, and the time of your treatment.
It usually takes about 60 minutes for each infusion.
When all of the medicine has been infused, turn off the pump.
Take the gauze off and remove the needle and tube from your skin.
Clean and store the infusion pump.

Missed dose

This medicine needs to be given on a fixed schedule. If you miss a dose or forget to use your medicine, call your doctor or pharmacist for instructions.

Storage

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Ask your healthcare professional how you should dispose of any medicine you do not use.

Store Hizentra® at room temperature, away from heat and moisture, for up to 30 months. Keep from freezing. Protect the product from direct light. Keep the medicine in its original package until you are ready to use it.

Store Gamunex®-C in its original container and in the refrigerator, but do not freeze it.

You may store Gammagard Liquid or Gammaked™ in the refrigerator or at room temperature. Store it in the original container. Do not freeze. Talk with your pharmacist if you have questions about storage of this product.

Store Cuvitru® at room temperature, away from heat and moisture, for up to 24 months or in the refrigerator for up to 36 months. Do not freeze. Do not shake. Protect the product from direct light. Keep the medicine in its original package until you are ready to use it.

Throw away used needles and tubes in a hard, closed container where the needles cannot poke through. Keep this container away from children and pets.

Precautions while using Xembify

It is very important that your doctor check your progress at regular visits for any problems that may be caused by this medicine. Blood and urine tests may be needed to check for unwanted effects.

Patients with idiopathic thrombocytopenic purpura (ITP) should not be treated with Gammaked™ or Gamunex®-C that is injected under the skin (subcutaneously). Doing so may increase the risk of having a hematoma (buildup of blood under the skin).

This medicine may cause fever, chills, flushing, headaches, nausea, and vomiting, especially if you are receiving it for the first time or if you have not received it for more than 8 weeks. Check with your doctor or nurse right away if you have any of these symptoms.

This medicine is made from donated human blood. Some human blood products have transmitted certain viruses to people who have received them, although the risk is low. Human donors and donated blood are both tested for viruses to keep the transmission risk low. Talk with your doctor if you have concerns about this risk.

This medicine may cause a serious type of allergic reaction, including anaphylaxis, which can be life-threatening and requires immediate medical attention. Tell your doctor right away if you have a rash, itching, hives, chest pain, dizziness or lightheadedness, trouble breathing, trouble swallowing, or any swelling of your hands, face, or mouth after receiving this medicine. Certain people, including those with IgA (an immunoglobulin) deficiency and antibodies against IgA and a history of hypersensitivity to human immunoglobulin products should not use this medicine.

Check with your doctor right away if you start to have a stiff neck, drowsiness, fever, severe headache, nausea, vomiting, painful eye movements, or eye sensitivity to light. These could be symptoms of a serious condition called aseptic meningitis syndrome (AMS).

This medicine may cause bleeding (hemolysis) or hemolytic anemia. Tell your doctor right away if you have stomach or back pain, dark urine, decreased urination, difficulty with breathing, an increased heart rate, tiredness, or yellow eyes or skin after you receive the medicine.

Check with your doctor right away if you start having chest pain, difficult, fast, or noisy breathing, blue lips and fingernails, fever, pale skin, increased sweating, coughing that sometimes produces a pink frothy sputum, trouble breathing, or swelling of the legs and ankles after receiving this medicine. These may be symptoms of a serious lung problem, including transfusion-related acute lung injury (TRALI).

This medicine may cause blood clots. This is more likely to occur if you have a history of blood clotting problems, heart disease, or atherosclerosis (hardening of the arteries), or if you are obese, take medicines containing estrogen, or must stay in bed for a long time because of surgery or illness. Check with your doctor right away if you suddenly have chest pain, severe headache, leg pain, or problems with vision, speech, or walking.

Check with your doctor right away if you start having red or dark brown urine, lower back or side pain, sudden weight gain, swollen face, arms, or legs, decreased urine output, or any problems with urination after you receive this medicine. These may be symptoms of a serious kidney problem.

Your blood pressure might get too high while you are using this medicine. This may cause headaches, dizziness, or blurred vision. You might need to measure your blood pressure at home. If you think your blood pressure is too high, call your doctor right away.

Make sure any doctor or dentist who treats you knows that you are using this medicine. This medicine may affect the results of certain medical tests.

Xembify side effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur:

More common

Back pain
black, tarry stools
blurred vision
bone pain
chest pain or tightness
chills
cough
dark urine
decreased urination
diarrhea
dizziness
fast, pounding, or irregular heartbeat or pulse
fever
general feeling of discomfort or illness
headache
joint pain
loss of appetite
muscle aches and pains
nausea
nervousness
noisy breathing
pain in the arms or legs
painful or difficult urination
pounding in the ears
rash
runny nose
shivering
slow or fast heartbeat
sore throat
sores, ulcers, or white spots on the lips or in the mouth
stomach pain
sweating
swollen glands
trouble breathing
trouble sleeping
unusual bleeding or bruising
unusual tiredness or weakness
vomiting
yellow eyes or skin

Less common

Bluish coloring of the lips or nail beds
burning sensation in the head
faintness or lightheadedness

Rare

Difficulty with swallowing
hives or welts
itching, especially of the feet or hands
reddening of the skin, especially around the ears
swelling of the eyes, face, or inside of the nose

Incidence not known

Back, leg, or stomach pains
blistering, peeling, or loosening of the skin
blood in the urine
change in vision
changes in blood pressure
changes in urination
chest pain or discomfort
cold, clammy, or pale skin
confusion
decreased frequency or amount of urine
difficult or labored breathing
difficulty seeing at night
dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
feeling of warmth
headache that is severe and occurs suddenly
hoarseness
increased sensitivity of the eyes to sunlight
increased thirst
irritation
joint stiffness or swelling
light-colored stools
loss of appetite
loss of consciousness
low blood pressure or pulse
lower back or side pain
muscle spasm or jerking of all extremities
pains in the chest, groin, or legs, especially calves of the legs
puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
seizures
shakiness in the legs, arms, hands, or feet
skin blisters
slow breathing
slurred speech that occurs suddenly
sudden, severe weakness or numbness in the arm or leg
sweating
swelling of the face, fingers, lower legs, or ankles
weight gain

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Lack or loss of strength
redness, swelling, itching, or pain at the injection site

Less common

Hip pain
leg cramps

Incidence not known

Anxiety
dry mouth
hair loss, thinning of hair
nervousness

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

','2023-03-10 21:04:55','2023-03-10 21:04:55'); INSERT INTO `default`.drags_translation (drag_id,language_id,title,content,created_at,updated_at) VALUES (15462,3,'Xembify (subcutaneous)','

Xembify (subcutaneous)

Generic name: immune globulin (subcutaneous) [ im-MYOON-GLOB-yoo-lin ]
Brand names: Cutaquig, Cuvitru, Hizentra, Xembify
Drug class: Immune globulins

Medically reviewed by Drugs.com on Feb 16, 2023. Written by Cerner Multum.

What is Xembify?

Xembify (for injection under the skin) is used to treat primary immunodeficiency diseases.

Xembify is also used to treat chronic inflammatory demyelinating polyneuropathy (an autoimmune disorder in which the immune system attacks the nerves, causing muscle weakness and numbness).

Xembify may also be used for purposes not listed in this medication guide.

Warnings

Xembify can cause blood clots. The risk is highest in older adults or in people who have had blood clots, heart problems, or blood circulation problems. Blood clots are also more likely during long-term bedrest, while using birth control pills or hormone replacement therapy, or while having a central intravenous (IV) catheter in place.

Call your doctor at once if you have chest pain, trouble breathing, fast heartbeats, numbness or weakness, or swelling and warmth or discoloration in an arm or leg.

This medicine can also harm your kidneys, especially if you have kidney disease or if you also use certain medicines. Tell your doctor right away if you have signs of kidney problems, such as swelling, rapid weight gain, and little or no urination.

Before taking this medicine

You should not use this medicine if:

you have had an allergic reaction to an Xembify or blood product; or
you have Xembify A (IgA) deficiency with antibody to IgA.

You may not be able to use Xembify if you have ever had an allergic reaction to polysorbate 80, or if you have a condition called hyperprolinemia (high level of a certain amino acid in the blood).

This medicine can cause blood clots or kidney problems, especially in older adults or in people with certain conditions. Tell your doctor if you have ever had:

heart problems, blood circulation problems, or "thick blood";
a stroke or blood clot;
kidney disease;
diabetes;
an infection called sepsis;
if you use estrogens (birth control pills or hormone replacement therapy);
if you have been on long-term bedrest; or
if you have a central intravenous (IV) catheter in place.

You may need a dose adjustment if you are exposed to measles, or if you travel to an area where this disease is common.

Tell your doctor if you are pregnant or breastfeeding.

Do not give this medicine to a child without medical advice.

Xembify is made from donated human plasma and may contain viruses or other infectious agents. Donated plasma is tested and treated to reduce the risk of contamination, but there is still a small possibility it could transmit disease. Ask your doctor about any possible risk.

How is Xembify given?

Xembify is injected under the skin using an infusion pump. The medicine enters the body through a catheter placed under your skin. A healthcare provider may teach you how to properly use the medication by yourself.

Xembify is sometimes given daily, and sometimes once every 1 to 2 weeks. Use Xembify at regular intervals to keep a steady amount of the drug in your body at all times. If you use this medication at home, keep a diary of the days and times you gave the injection and where you injected it on your body.

Xembify must be given slowly, and you may need to use up to 8 different catheters to infuse this medicine into different body areas at the same time. Your healthcare provider will show you where on your body to inject this medicine. Use a different place each time you give an injection. Do not inject into the same place two times in a row.

Read and carefully follow any Instructions for Use provided with your medicine. Ask your doctor or pharmacist if you don''t understand all instructions.

Prepare an injection only when you are ready to give it. Do not use if the medicine has is cloudy, has changed colors, or has particles in it. Call your pharmacist for new medicine.

Do not shake the medication bottle or you may ruin the medicine.

Do not inject Xembify into a vein.

You will need frequent blood tests. This medicine can affect the results of certain other medical tests you may need. Tell any doctor who treats you that you are using Xembify.

Store Xembify in the original carton at room temperature. Protect from heat and light.

You may also store this medicine in its original carton in the refrigerator. Do not freeze Xembify, and throw the medicine away if it has frozen.

You will need to use your medicine within a certain number months. This will depend on the how you store the medicine (at room temperature, or in a refrigerator). Carefully follow the storage instructions provided with your medicine. Ask your pharmacist if you have questions.

Throw away any unused medication after the expiration date on the label has passed.

Each vial (bottle) is for one use only. Throw it away after one use, even if there is still medicine left inside.

Use disposable injection items (needle, catheter, tubing) only once only once and then place them in a puncture-proof "sharps" container. Follow state or local laws about how to dispose of this container. Keep it out of the reach of children and pets.

Detailed Xembify dosage information

What happens if I miss a dose?

Call your doctor for instructions if you miss a dose.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Xembify?

Do not receive a "live" vaccine while using Xembify. The vaccine may not work as well and may not fully protect you from disease. Live vaccines include measles, mumps, rubella (MMR), rotavirus, typhoid, yellow fever, varicella (chickenpox), zoster (shingles), and nasal flu (influenza) vaccine.

Xembify side effects

Stop using Xembify and get emergency medical help if you have signs of an allergic reaction: hives; wheezing, chest tightness, difficult breathing; dizziness, feeling like you might pass out; swelling of your face, lips, tongue, or throat.

Xembify may cause serious side effects. Call your doctor at once if you have:

a blood cell disorder--pale or yellowed skin, dark colored urine, fever, confusion or weakness;
kidney problems--little or no urination, swelling, rapid weight gain, feeling short of breath;
lung problems--chest pain, trouble breathing, blue colored lips, fingers, or toes;
signs of a new infection--fever with a severe headache, neck stiffness, eye pain, and increased sensitivity to light; or
signs of a blood clot--shortness of breath, chest pain with deep breathing, rapid heart rate, numbness or weakness on one side of the body, swelling and warmth or discoloration in an arm or leg.

Common side effects of Xembify may include:

wheezing, trouble breathing;
pain, redness, bruising, itching, swelling, or a hard lump where the medicine was injected;
fever, tiredness, dizziness;
nausea, vomiting, diarrhea, bloating, stomach pain;
itching, rash, or other skin problems;
cold or flu symptoms such as stuffy nose, sneezing, sore throat, cough;
headache, migraine; or
pain anywhere in your body.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Xembify side effects (more detail)

What other drugs will affect Xembify?

Xembify can harm your kidneys, especially if you also use certain medicines for infections, cancer, osteoporosis, organ transplant rejection, bowel disorders, high blood pressure, or pain or arthritis (including Advil, Motrin, and Aleve).

Other drugs may affect Xembify, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Xembify drug interactions (more detail)

Where can I get more information?

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

More about Xembify (immune globulin subcutaneous)

Check interactions
Pricing & coupons
Latest FDA alerts (1)
Side effects
Dosage information
During pregnancy
FDA approval history
Drug class: immune globulins
En español

Patient resources

Advanced Reading
Xembify

Other brands

Hizentra, Cuvitru, Cutaquig, Vivaglobin

Professional resources

Prescribing Information

Related treatment guides

Primary Immunodeficiency Syndrome

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Drug name: Xembify

Xembify

Commonly used brand name(s)

Uses for Xembify

Before using Xembify

Allergies

Pediatric

Geriatric

Breastfeeding

Interactions with medicines

Interactions with food/tobacco/alcohol

Other medical problems

Proper use of Xembify

Missed dose

Storage

Precautions while using Xembify

Xembify side effects

Further information

Xembify (subcutaneous)

What is Xembify?

Warnings

Before taking this medicine

How is Xembify given?

What happens if I miss a dose?

What happens if I overdose?

What should I avoid while using Xembify?

Xembify side effects

What other drugs will affect Xembify?

Where can I get more information?

More about Xembify (immune globulin subcutaneous)

Patient resources

Other brands

Professional resources

Related treatment guides

Further information